🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6797721

Phorboxazole derivatives for treating cancer

Regents of the University of Minnesota · Granted Tue Sep 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6787536

Hydroxamic acid derivatives

Darwin Discovery Limited · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6784314

Process for producing amine derivatives

Takeda Chemical Industries Ltd. · Granted Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6780995

Activated iododerivatives for the treatment of cancer and aids

Isotechnika, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6777435

Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Takeda Chemical Industries Ltd. · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6774180

Synthesis of high molecular weight non-peptidic polymer derivatives

Nektar Therapeutics AL, Corporation · Granted Tue Aug 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6770621

Polyacid glycopeptide derivatives

Theravance, Inc. · Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6764998

6,11-4C-bicyclic 9a-azalide derivatives

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6765016

Bicyclic ketolide derivatives

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6753415

23-O-substituted 5-O-mycaminosyltylonide derivatives

Enanta Pharmaceuticals, Inc. · Granted Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6753317

Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750226

Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

Almirall Prodesfarma S.A. · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6747042

N-heterocyclic derivatives

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6743924

Method for producing 1-substituted-1,2,3-triazole derivative

Takeda Chemical Industries Ltd. · Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6737505

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6734189

Hydroxamic and carboxylic acid derivatives

Darwin Discovery Limited · Granted Tue May 11 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6723722

Acylhydrazine derivatives, their production and use

Takeda Chemical Industries Ltd. · Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6720308

Anhydrolide derivatives having antibacterial activity

Enanta Pharmaceuticals, Inc. · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6716860

Azo amino acids derivatives

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6713478

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6710034

5-O-mycaminosyltylonide derivatives

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6706719

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6706732

Nasal preparation of guanidinoimino quinoline derivatives

Takeda Chemical Industries Ltd. · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693103

1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired